Electrotherapy plus two drugs vs drug alone for vulvar cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This Phase 2 study compares adding electrotherapy to give carboplatin plus bleomycin directly to the tumor versus giving bleomycin alone. It may help shrink recurrent vulvar cancer when standard options aren’t suitable and your health is limited.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- Your vulvar cancer has come back, confirmed by biopsy (histology)
- You’ve already had multiple prior treatments such as surgery and radiation, and/or chemotherapy with radiation
- Standard treatments aren’t a good option for you because you’re quite unwell (ECOG performance status 3 or higher)
- You have a measurable tumor you can track on scans (RECIST 1.1)
- Your blood tests and organ function (kidney, liver, blood counts) must be in allowed ranges near treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a targeted electric current can improve treatment for vulvar cancer that has returned after standard therapy. The treatment uses electricity to help chemotherapy drugs enter cancer cells more effectively.
This Phase 2 trial tests AK104 in people with recurrent or metastatic vulvar cancer that cannot be cured with surgery or strong radiation. It may help shrink tumors or slow growth, especially if you’ve already tried standard treatments or couldn’t tolerate them.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
This trial tests a treatment called electrochemotherapy for tumors in internal organs (like the liver or pancreas) when standard treatments are no longer possible. It uses a drug called bleomycin plus electric pulses to target cancer cells.
This Phase 2 study tests electrotherapy (a way to help treatment reach tumor cells) for gynecologic cancers that have come back after standard treatments were used up. You may be considered if your overall health allows anesthesia and if certain cancer spread and medical safety issues do not apply.
This Phase 2 trial compares two treatment approaches for some women with vulvar squamous cell cancer: chemoradiation first, or chemotherapy first followed by surgery. The goal is to see which strategy works better or is safer for tumors that are hard to remove without major pelvic surgery.
Hear when a new Vulvar Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.